Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Targeted Immunomodulation in Patients With ARDS Related to COVID19 and Future Pandemic Pathogens

NCT06311448 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06311448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06311448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Targeted Immunomodulation in Patients With ARDS Related to COVID19 and Future Pandemic Pathogens
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Completed
Start date
March 2, 2020
Completion date
February 1, 2022
Enrollment
164 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 acute respiratory distress syndrome